Pediatrix Medical ROE 2010-2025 | MD
Current and historical return on equity (ROE) values for Pediatrix Medical (MD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Pediatrix Medical ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $-0.08B | $0.79B | -11.10% |
| 2024-12-31 | $-0.10B | $0.77B | -13.08% |
| 2024-09-30 | $-0.25B | $0.73B | -32.33% |
| 2024-06-30 | $-0.25B | $0.71B | -29.83% |
| 2024-03-31 | $-0.07B | $0.86B | -7.86% |
| 2023-12-31 | $-0.06B | $0.85B | -6.65% |
| 2023-09-30 | $0.09B | $0.97B | 10.02% |
| 2023-06-30 | $0.10B | $0.94B | 11.43% |
| 2023-03-31 | $0.10B | $0.91B | 11.64% |
| 2022-12-31 | $0.07B | $0.89B | 7.72% |
| 2022-09-30 | $0.09B | $0.86B | 9.78% |
| 2022-06-30 | $0.09B | $0.85B | 9.81% |
| 2022-03-31 | $0.09B | $0.88B | 10.85% |
| 2021-12-31 | $0.13B | $0.90B | 15.91% |
| 2021-09-30 | $0.02B | $0.85B | 2.52% |
| 2021-06-30 | $-0.05B | $0.81B | -6.65% |
| 2021-03-31 | $-0.76B | $0.77B | -96.47% |
| 2020-12-31 | $-0.80B | $0.75B | -82.34% |
| 2020-09-30 | $-0.72B | $0.81B | -62.62% |
| 2020-06-30 | $-1.94B | $0.83B | -146.49% |
| 2020-03-31 | $-1.27B | $1.49B | -70.88% |
| 2019-12-31 | $-1.50B | $1.50B | -70.64% |
| 2019-09-30 | $-1.45B | $1.48B | -57.47% |
| 2019-06-30 | $-0.13B | $2.73B | -4.31% |
| 2019-03-31 | $-0.04B | $2.78B | -1.26% |
| 2018-12-31 | $0.27B | $3.09B | 8.62% |
| 2018-09-30 | $0.34B | $3.02B | 11.09% |
| 2018-06-30 | $0.34B | $3.19B | 11.18% |
| 2018-03-31 | $0.33B | $3.14B | 11.00% |
| 2017-12-31 | $0.32B | $3.07B | 11.09% |
| 2017-09-30 | $0.26B | $2.92B | 9.33% |
| 2017-06-30 | $0.29B | $2.84B | 10.66% |
| 2017-03-31 | $0.31B | $2.76B | 11.61% |
| 2016-12-31 | $0.33B | $2.76B | 12.44% |
| 2016-09-30 | $0.34B | $2.67B | 13.43% |
| 2016-06-30 | $0.33B | $2.56B | 13.65% |
| 2016-03-31 | $0.34B | $2.46B | 14.22% |
| 2015-12-31 | $0.34B | $2.44B | 14.80% |
| 2015-09-30 | $0.33B | $2.33B | 14.86% |
| 2015-06-30 | $0.33B | $2.22B | 14.37% |
| 2015-03-31 | $0.32B | $2.11B | 13.86% |
| 2014-12-31 | $0.32B | $2.27B | 13.37% |
| 2014-09-30 | $0.31B | $2.51B | 12.89% |
| 2014-06-30 | $0.30B | $2.41B | 12.88% |
| 2014-03-31 | $0.29B | $2.31B | 12.74% |
| 2013-12-31 | $0.28B | $2.34B | 12.62% |
| 2013-09-30 | $0.27B | $2.23B | 12.46% |
| 2013-06-30 | $0.26B | $2.19B | 12.36% |
| 2013-03-31 | $0.25B | $2.11B | 12.46% |
| 2012-12-31 | $0.24B | $2.04B | 12.60% |
| 2012-09-30 | $0.23B | $1.95B | 12.68% |
| 2012-06-30 | $0.23B | $1.87B | 12.75% |
| 2012-03-31 | $0.22B | $1.80B | 12.98% |
| 2011-12-31 | $0.22B | $1.73B | 13.38% |
| 2011-09-30 | $0.21B | $1.66B | 13.73% |
| 2011-06-30 | $0.22B | $1.59B | 14.60% |
| 2011-03-31 | $0.21B | $1.51B | 14.86% |
| 2010-12-31 | $0.20B | $1.45B | 15.08% |
| 2010-09-30 | $0.20B | $1.37B | 15.53% |
| 2010-06-30 | $0.19B | $1.30B | 15.27% |
| 2010-03-31 | $0.18B | $1.24B | 15.56% |
| 2009-12-31 | $0.18B | $1.19B | 16.02% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.080B | $2.013B |
| Pediatrix Medical Group Inc. is a national medical group comprised of physician services practicing under the Pediatrix(R) brand. It provides services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Pediatrix Medical Group Inc., formerly known as Mednax Inc., is based in FORT LAUDERDALE, Fla. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.134B | 27.29 |
| CVS Health (CVS) | United States | $76.787B | 9.54 |
| Elevance Health (ELV) | United States | $65.099B | 8.76 |
| Cencora (COR) | United States | $56.279B | 19.58 |
| DiDi Global (DIDIY) | China | $25.745B | 27.35 |
| Labcorp Holdings (LH) | United States | $22.177B | 17.50 |
| Natera (NTRA) | United States | $18.966B | 0.00 |
| BioMerieux (BMXMF) | France | $17.681B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.851B | 0.00 |
| ICON (ICLR) | Ireland | $15.102B | 14.53 |
| CochLear (CHEOY) | Australia | $13.402B | 0.00 |
| Solventum (SOLV) | United States | $12.933B | 13.69 |
| Medpace Holdings (MEDP) | United States | $12.571B | 33.27 |
| Revvity (RVTY) | United States | $12.220B | 21.03 |
| Viatris (VTRS) | United States | $11.044B | 3.79 |
| Avantor (AVTR) | United States | $9.683B | 14.07 |
| Sonic Healthcare (SKHHY) | Australia | $9.143B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.690B | 17.03 |
| HealthEquity (HQY) | United States | $8.305B | 36.38 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.515B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.066B | 29.83 |
| BrightSpring Health Services (BTSG) | United States | $3.609B | 33.11 |
| Sotera Health (SHC) | United States | $3.491B | 19.84 |
| Surgery Partners (SGRY) | United States | $2.725B | 35.43 |
| Organon (OGN) | United States | $2.654B | 2.82 |
| Concentras Parent (CON) | United States | $2.520B | 14.56 |
| Alignment Healthcare (ALHC) | United States | $2.327B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.278B | 87.72 |
| Progyny (PGNY) | United States | $1.981B | 43.60 |
| GoodRx Holdings (GDRX) | United States | $1.786B | 35.71 |
| PACS (PACS) | United States | $1.782B | 0.00 |
| Premier (PINC) | United States | $1.744B | 13.23 |
| Ardent Health (ARDT) | United States | $1.582B | 6.74 |
| Teladoc Health (TDOC) | United States | $1.439B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.226B | 0.00 | |
| QDM (QDMI) | Hong Kong, SAR China | $0.997B | 342.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.853B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.758B | 7.10 |
| CareDx (CDNA) | United States | $0.712B | 11.12 |
| Embecta (EMBC) | United States | $0.686B | 4.62 |
| Nutex Health (NUTX) | United States | $0.528B | 7.99 |
| InnovAge Holding (INNV) | United States | $0.518B | 0.00 |
| Omada Health (OMDA) | $0.495B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.493B | 0.00 |
| LifeMD (LFMD) | United States | $0.486B | 0.00 |
| So-Young (SY) | China | $0.471B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.464B | 10.45 |
| Sonida Senior Living (SNDA) | United States | $0.461B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.405B | 0.00 |
| Enhabit (EHAB) | United States | $0.342B | 28.12 |
| Oncology Institute (TOI) | United States | $0.328B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.284B | 0.00 |
| Beauty Health (SKIN) | United States | $0.226B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.192B | 0.00 |
| DocGo (DCGO) | United States | $0.149B | 24.33 |
| Sera Prognostics (SERA) | United States | $0.122B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.090B | 0.00 |
| KindlyMD (NAKA) | United States | $0.080B | 0.00 |
| Biodesix (BDSX) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.044B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.042B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |